3658 results for «247»
3658 results
High-risk PCI in cardiogenic shock and calcified vessels
16 May 2023 – From EuroPCR 2023
Looking for a better insight into this session devoted to high-risk PCI in cardiogenic shock and calcified vessels? Revisit the slides presented and review the detailed results of a series of important studies conducted on the subject.
PCR's Got Talent - Round 1 - Session 2
16 May 2023 – From EuroPCR 2023
Did you participate in this session and want to enhance your memory? Take a look at the slides shared by the presenters and revisit the key points worth remembering.
Mitral and tricuspid valve intervention : new devices and clinical outcomes
17 May 2023 – From EuroPCR 2023
Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.
Bifurcations
17 May 2023 – From EuroPCR 2023
Seeking to revive your understanding of this session focusing on bifurcations? Examine these slides and review the main elements of the presentations.
TAVI 2: new devices, procedural refinements
19 May 2023 – From EuroPCR 2023
Seeking a recap of the TAVI Abstract session? Dive into the provided slides containing the main points of the presentation.
Novel treatment strategies in ACS patients
17 May 2023 – From EuroPCR 2023
Seeking to revive your understanding on novel strategies in ACS treatment? Explore this collection of resources to get insight on optimal antithrombotic therapy in AF patients post-PCI, complete revascularisation in ACS, and early invasive approaches in high-risk NSTEMI, among other topics.
STEMI Vignettes - The global classroom
18 May 2023 – From EuroPCR 2023
Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.
Coronary artery disease: more imaging, less imagination
18 May 2023 – From EuroPCR 2023
In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.
Endovascular management treatment
17 May 2023 – From EuroPCR 2023
In this series of resources, explore the toolbox for BTK bifurcation treatment with antegrade and retrograde management, navigate complex scenarios in superficial femoral artery and femoral bifurcation and elevate your expertise in carotid artery stenting managment.
PCR Valves e-Course: Sponsored Programme
EuroIntervention: Meet Cory, your new AI Assistant!
26 Mar 2024
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
All-new EuroPCR 2021: what’s on?
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
